[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

IPV Vaccine Market, Global Outlook and Forecast 2022-2028

June 2022 | 79 pages | ID: I76A39F7E142EN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report contains market size and forecasts of IPV Vaccine in global, including the following market information:

Global IPV Vaccine Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global IPV Vaccine Market Sales, 2017-2022, 2023-2028, (Units)

Global top five IPV Vaccine companies in 2021 (%)

The global IPV Vaccine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Mahoney Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of IPV Vaccine include GlaxoSmithKline Plc, Sanofi S.A, Serum Institute of India Pvt. Ltd., PT Bio Farma and AJ Vaccines, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the IPV Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global IPV Vaccine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Units)

Global IPV Vaccine Market Segment Percentages, by Type, 2021 (%)
  • Mahoney
  • MEF1
  • Saukett
Global IPV Vaccine Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Units)

Global IPV Vaccine Market Segment Percentages, by Application, 2021 (%)
  • Private Distribution Channel
  • Public Distribution Channel
Global IPV Vaccine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Units)

Global IPV Vaccine Market Segment Percentages, By Region and Country, 2021 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies IPV Vaccine revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies IPV Vaccine revenues share in global market, 2021 (%)

Key companies IPV Vaccine sales in global market, 2017-2022 (Estimated), (Units)

Key companies IPV Vaccine sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:
  • GlaxoSmithKline Plc
  • Sanofi S.A
  • Serum Institute of India Pvt. Ltd.
  • PT Bio Farma
  • AJ Vaccines
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 IPV Vaccine Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global IPV Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL IPV VACCINE OVERALL MARKET SIZE

2.1 Global IPV Vaccine Market Size: 2021 VS 2028
2.2 Global IPV Vaccine Revenue, Prospects & Forecasts: 2017-2028
2.3 Global IPV Vaccine Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top IPV Vaccine Players in Global Market
3.2 Top Global IPV Vaccine Companies Ranked by Revenue
3.3 Global IPV Vaccine Revenue by Companies
3.4 Global IPV Vaccine Sales by Companies
3.5 Global IPV Vaccine Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 IPV Vaccine Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers IPV Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 IPV Vaccine Players in Global Market
  3.8.1 List of Global Tier 1 IPV Vaccine Companies
  3.8.2 List of Global Tier 2 and Tier 3 IPV Vaccine Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global IPV Vaccine Market Size Markets, 2021 & 2028
  4.1.2 Mahoney
  4.1.3 MEF1
  4.1.4 Saukett
4.2 By Type - Global IPV Vaccine Revenue & Forecasts
  4.2.1 By Type - Global IPV Vaccine Revenue, 2017-2022
  4.2.2 By Type - Global IPV Vaccine Revenue, 2023-2028
  4.2.3 By Type - Global IPV Vaccine Revenue Market Share, 2017-2028
4.3 By Type - Global IPV Vaccine Sales & Forecasts
  4.3.1 By Type - Global IPV Vaccine Sales, 2017-2022
  4.3.2 By Type - Global IPV Vaccine Sales, 2023-2028
  4.3.3 By Type - Global IPV Vaccine Sales Market Share, 2017-2028
4.4 By Type - Global IPV Vaccine Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global IPV Vaccine Market Size, 2021 & 2028
  5.1.2 Private Distribution Channel
  5.1.3 Public Distribution Channel
5.2 By Application - Global IPV Vaccine Revenue & Forecasts
  5.2.1 By Application - Global IPV Vaccine Revenue, 2017-2022
  5.2.2 By Application - Global IPV Vaccine Revenue, 2023-2028
  5.2.3 By Application - Global IPV Vaccine Revenue Market Share, 2017-2028
5.3 By Application - Global IPV Vaccine Sales & Forecasts
  5.3.1 By Application - Global IPV Vaccine Sales, 2017-2022
  5.3.2 By Application - Global IPV Vaccine Sales, 2023-2028
  5.3.3 By Application - Global IPV Vaccine Sales Market Share, 2017-2028
5.4 By Application - Global IPV Vaccine Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global IPV Vaccine Market Size, 2021 & 2028
6.2 By Region - Global IPV Vaccine Revenue & Forecasts
  6.2.1 By Region - Global IPV Vaccine Revenue, 2017-2022
  6.2.2 By Region - Global IPV Vaccine Revenue, 2023-2028
  6.2.3 By Region - Global IPV Vaccine Revenue Market Share, 2017-2028
6.3 By Region - Global IPV Vaccine Sales & Forecasts
  6.3.1 By Region - Global IPV Vaccine Sales, 2017-2022
  6.3.2 By Region - Global IPV Vaccine Sales, 2023-2028
  6.3.3 By Region - Global IPV Vaccine Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America IPV Vaccine Revenue, 2017-2028
  6.4.2 By Country - North America IPV Vaccine Sales, 2017-2028
  6.4.3 US IPV Vaccine Market Size, 2017-2028
  6.4.4 Canada IPV Vaccine Market Size, 2017-2028
  6.4.5 Mexico IPV Vaccine Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe IPV Vaccine Revenue, 2017-2028
  6.5.2 By Country - Europe IPV Vaccine Sales, 2017-2028
  6.5.3 Germany IPV Vaccine Market Size, 2017-2028
  6.5.4 France IPV Vaccine Market Size, 2017-2028
  6.5.5 U.K. IPV Vaccine Market Size, 2017-2028
  6.5.6 Italy IPV Vaccine Market Size, 2017-2028
  6.5.7 Russia IPV Vaccine Market Size, 2017-2028
  6.5.8 Nordic Countries IPV Vaccine Market Size, 2017-2028
  6.5.9 Benelux IPV Vaccine Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia IPV Vaccine Revenue, 2017-2028
  6.6.2 By Region - Asia IPV Vaccine Sales, 2017-2028
  6.6.3 China IPV Vaccine Market Size, 2017-2028
  6.6.4 Japan IPV Vaccine Market Size, 2017-2028
  6.6.5 South Korea IPV Vaccine Market Size, 2017-2028
  6.6.6 Southeast Asia IPV Vaccine Market Size, 2017-2028
  6.6.7 India IPV Vaccine Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America IPV Vaccine Revenue, 2017-2028
  6.7.2 By Country - South America IPV Vaccine Sales, 2017-2028
  6.7.3 Brazil IPV Vaccine Market Size, 2017-2028
  6.7.4 Argentina IPV Vaccine Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa IPV Vaccine Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa IPV Vaccine Sales, 2017-2028
  6.8.3 Turkey IPV Vaccine Market Size, 2017-2028
  6.8.4 Israel IPV Vaccine Market Size, 2017-2028
  6.8.5 Saudi Arabia IPV Vaccine Market Size, 2017-2028
  6.8.6 UAE IPV Vaccine Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 GlaxoSmithKline Plc
  7.1.1 GlaxoSmithKline Plc Corporate Summary
  7.1.2 GlaxoSmithKline Plc Business Overview
  7.1.3 GlaxoSmithKline Plc IPV Vaccine Major Product Offerings
  7.1.4 GlaxoSmithKline Plc IPV Vaccine Sales and Revenue in Global (2017-2022)
  7.1.5 GlaxoSmithKline Plc Key News
7.2 Sanofi S.A
  7.2.1 Sanofi S.A Corporate Summary
  7.2.2 Sanofi S.A Business Overview
  7.2.3 Sanofi S.A IPV Vaccine Major Product Offerings
  7.2.4 Sanofi S.A IPV Vaccine Sales and Revenue in Global (2017-2022)
  7.2.5 Sanofi S.A Key News
7.3 Serum Institute of India Pvt. Ltd.
  7.3.1 Serum Institute of India Pvt. Ltd. Corporate Summary
  7.3.2 Serum Institute of India Pvt. Ltd. Business Overview
  7.3.3 Serum Institute of India Pvt. Ltd. IPV Vaccine Major Product Offerings
  7.3.4 Serum Institute of India Pvt. Ltd. IPV Vaccine Sales and Revenue in Global (2017-2022)
  7.3.5 Serum Institute of India Pvt. Ltd. Key News
7.4 PT Bio Farma
  7.4.1 PT Bio Farma Corporate Summary
  7.4.2 PT Bio Farma Business Overview
  7.4.3 PT Bio Farma IPV Vaccine Major Product Offerings
  7.4.4 PT Bio Farma IPV Vaccine Sales and Revenue in Global (2017-2022)
  7.4.5 PT Bio Farma Key News
7.5 AJ Vaccines
  7.5.1 AJ Vaccines Corporate Summary
  7.5.2 AJ Vaccines Business Overview
  7.5.3 AJ Vaccines IPV Vaccine Major Product Offerings
  7.5.4 AJ Vaccines IPV Vaccine Sales and Revenue in Global (2017-2022)
  7.5.5 AJ Vaccines Key News

8 GLOBAL IPV VACCINE PRODUCTION CAPACITY, ANALYSIS

8.1 Global IPV Vaccine Production Capacity, 2017-2028
8.2 IPV Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global IPV Vaccine Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 IPV VACCINE SUPPLY CHAIN ANALYSIS

10.1 IPV Vaccine Industry Value Chain
10.2 IPV Vaccine Upstream Market
10.3 IPV Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 IPV Vaccine Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

LIST OF TABLES

Table 1. Key Players of IPV Vaccine in Global Market
Table 2. Top IPV Vaccine Players in Global Market, Ranking by Revenue (2021)
Table 3. Global IPV Vaccine Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global IPV Vaccine Revenue Share by Companies, 2017-2022
Table 5. Global IPV Vaccine Sales by Companies, (Units), 2017-2022
Table 6. Global IPV Vaccine Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers IPV Vaccine Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers IPV Vaccine Product Type
Table 9. List of Global Tier 1 IPV Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 IPV Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global IPV Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global IPV Vaccine Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global IPV Vaccine Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global IPV Vaccine Sales (Units), 2017-2022
Table 15. By Type - Global IPV Vaccine Sales (Units), 2023-2028
Table 16. By Application – Global IPV Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global IPV Vaccine Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global IPV Vaccine Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global IPV Vaccine Sales (Units), 2017-2022
Table 20. By Application - Global IPV Vaccine Sales (Units), 2023-2028
Table 21. By Region – Global IPV Vaccine Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global IPV Vaccine Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global IPV Vaccine Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global IPV Vaccine Sales (Units), 2017-2022
Table 25. By Region - Global IPV Vaccine Sales (Units), 2023-2028
Table 26. By Country - North America IPV Vaccine Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America IPV Vaccine Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America IPV Vaccine Sales, (Units), 2017-2022
Table 29. By Country - North America IPV Vaccine Sales, (Units), 2023-2028
Table 30. By Country - Europe IPV Vaccine Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe IPV Vaccine Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe IPV Vaccine Sales, (Units), 2017-2022
Table 33. By Country - Europe IPV Vaccine Sales, (Units), 2023-2028
Table 34. By Region - Asia IPV Vaccine Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia IPV Vaccine Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia IPV Vaccine Sales, (Units), 2017-2022
Table 37. By Region - Asia IPV Vaccine Sales, (Units), 2023-2028
Table 38. By Country - South America IPV Vaccine Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America IPV Vaccine Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America IPV Vaccine Sales, (Units), 2017-2022
Table 41. By Country - South America IPV Vaccine Sales, (Units), 2023-2028
Table 42. By Country - Middle East & Africa IPV Vaccine Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa IPV Vaccine Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa IPV Vaccine Sales, (Units), 2017-2022
Table 45. By Country - Middle East & Africa IPV Vaccine Sales, (Units), 2023-2028
Table 46. GlaxoSmithKline Plc Corporate Summary
Table 47. GlaxoSmithKline Plc IPV Vaccine Product Offerings
Table 48. GlaxoSmithKline Plc IPV Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Sanofi S.A Corporate Summary
Table 50. Sanofi S.A IPV Vaccine Product Offerings
Table 51. Sanofi S.A IPV Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Serum Institute of India Pvt. Ltd. Corporate Summary
Table 53. Serum Institute of India Pvt. Ltd. IPV Vaccine Product Offerings
Table 54. Serum Institute of India Pvt. Ltd. IPV Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. PT Bio Farma Corporate Summary
Table 56. PT Bio Farma IPV Vaccine Product Offerings
Table 57. PT Bio Farma IPV Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. AJ Vaccines Corporate Summary
Table 59. AJ Vaccines IPV Vaccine Product Offerings
Table 60. AJ Vaccines IPV Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. IPV Vaccine Production Capacity (Units) of Key Manufacturers in Global Market, 2020-2022 (Units)
Table 62. Global IPV Vaccine Capacity Market Share of Key Manufacturers, 2020-2022
Table 63. Global IPV Vaccine Production by Region, 2017-2022 (Units)
Table 64. Global IPV Vaccine Production by Region, 2023-2028 (Units)
Table 65. IPV Vaccine Market Opportunities & Trends in Global Market
Table 66. IPV Vaccine Market Drivers in Global Market
Table 67. IPV Vaccine Market Restraints in Global Market
Table 68. IPV Vaccine Raw Materials
Table 69. IPV Vaccine Raw Materials Suppliers in Global Market
Table 70. Typical IPV Vaccine Downstream
Table 71. IPV Vaccine Downstream Clients in Global Market
Table 72. IPV Vaccine Distributors and Sales Agents in Global Market

LIST OF FIGURES

Figure 1. IPV Vaccine Segment by Type
Figure 2. IPV Vaccine Segment by Application
Figure 3. Global IPV Vaccine Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global IPV Vaccine Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global IPV Vaccine Revenue, 2017-2028 (US$, Mn)
Figure 7. IPV Vaccine Sales in Global Market: 2017-2028 (Units)
Figure 8. The Top 3 and 5 Players Market Share by IPV Vaccine Revenue in 2021
Figure 9. By Type - Global IPV Vaccine Sales Market Share, 2017-2028
Figure 10. By Type - Global IPV Vaccine Revenue Market Share, 2017-2028
Figure 11. By Type - Global IPV Vaccine Price (US$/Unit), 2017-2028
Figure 12. By Application - Global IPV Vaccine Sales Market Share, 2017-2028
Figure 13. By Application - Global IPV Vaccine Revenue Market Share, 2017-2028
Figure 14. By Application - Global IPV Vaccine Price (US$/Unit), 2017-2028
Figure 15. By Region - Global IPV Vaccine Sales Market Share, 2017-2028
Figure 16. By Region - Global IPV Vaccine Revenue Market Share, 2017-2028
Figure 17. By Country - North America IPV Vaccine Revenue Market Share, 2017-2028
Figure 18. By Country - North America IPV Vaccine Sales Market Share, 2017-2028
Figure 19. US IPV Vaccine Revenue, (US$, Mn), 2017-2028
Figure 20. Canada IPV Vaccine Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico IPV Vaccine Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe IPV Vaccine Revenue Market Share, 2017-2028
Figure 23. By Country - Europe IPV Vaccine Sales Market Share, 2017-2028
Figure 24. Germany IPV Vaccine Revenue, (US$, Mn), 2017-2028
Figure 25. France IPV Vaccine Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. IPV Vaccine Revenue, (US$, Mn), 2017-2028
Figure 27. Italy IPV Vaccine Revenue, (US$, Mn), 2017-2028
Figure 28. Russia IPV Vaccine Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries IPV Vaccine Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux IPV Vaccine Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia IPV Vaccine Revenue Market Share, 2017-2028
Figure 32. By Region - Asia IPV Vaccine Sales Market Share, 2017-2028
Figure 33. China IPV Vaccine Revenue, (US$, Mn), 2017-2028
Figure 34. Japan IPV Vaccine Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea IPV Vaccine Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia IPV Vaccine Revenue, (US$, Mn), 2017-2028
Figure 37. India IPV Vaccine Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America IPV Vaccine Revenue Market Share, 2017-2028
Figure 39. By Country - South America IPV Vaccine Sales Market Share, 2017-2028
Figure 40. Brazil IPV Vaccine Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina IPV Vaccine Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa IPV Vaccine Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa IPV Vaccine Sales Market Share, 2017-2028
Figure 44. Turkey IPV Vaccine Revenue, (US$, Mn), 2017-2028
Figure 45. Israel IPV Vaccine Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia IPV Vaccine Revenue, (US$, Mn), 2017-2028
Figure 47. UAE IPV Vaccine Revenue, (US$, Mn), 2017-2028
Figure 48. Global IPV Vaccine Production Capacity (Units), 2017-2028
Figure 49. The Percentage of Production IPV Vaccine by Region, 2021 VS 2028
Figure 50. IPV Vaccine Industry Value Chain
Figure 51. Marketing Channels


More Publications